Global Endoparasiticide Sales Market Report 2024

Report ID: 886515 | Published Date: Apr 2026 | No. of Page: 133 | Base Year: 2025 | Rating: 3.7
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Endoparasiticide Market Overview
    1.1 Endoparasiticide Product Scope
    1.2 Endoparasiticide Segment by Type
        1.2.1 Global Endoparasiticide Sales by Type (2016 & 2021 & 2027)
        1.2.2 Ear Tags
        1.2.3 Tablets
        1.2.4 Injectables
        1.2.5 Feed Additives
    1.3 Endoparasiticide Segment by Application
        1.3.1 Global Endoparasiticide Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Veterinary Hospitals or Clinics
        1.3.3 Animal Farms
        1.3.4 Home Care Settings
    1.4 Endoparasiticide Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Endoparasiticide Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Endoparasiticide Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Endoparasiticide Price Trends (2016-2027)

2 Endoparasiticide Estimates and Forecasts by Region
    2.1 Global Endoparasiticide Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Endoparasiticide Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Endoparasiticide Sales Market Share by Region (2016-2021)
        2.2.2 Global Endoparasiticide Revenue Market Share by Region (2016-2021)
    2.3 Global Endoparasiticide Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Endoparasiticide Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Endoparasiticide Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Endoparasiticide Estimates and Projections (2016-2027)
        2.4.2 Europe Endoparasiticide Estimates and Projections (2016-2027)
        2.4.3 China Endoparasiticide Estimates and Projections (2016-2027)
        2.4.4 Japan Endoparasiticide Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Endoparasiticide Estimates and Projections (2016-2027)
        2.4.6 India Endoparasiticide Estimates and Projections (2016-2027)
3 Global Endoparasiticide Competition Landscape by Players
    3.1 Global Top Endoparasiticide Players by Sales (2016-2021)
    3.2 Global Top Endoparasiticide Players by Revenue (2016-2021)
    3.3 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endoparasiticide as of 2020)
    3.4 Global Endoparasiticide Average Price by Company (2016-2021)
    3.5 Manufacturers Endoparasiticide Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Endoparasiticide Market Size by Type
    4.1 Global Endoparasiticide Historic Market Review by Type (2016-2021)
        4.1.1 Global Endoparasiticide Sales Market Share by Type (2016-2021)
        4.1.2 Global Endoparasiticide Revenue Market Share by Type (2016-2021)
        4.1.3 Global Endoparasiticide Price by Type (2016-2021)
    4.2 Global Endoparasiticide Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Endoparasiticide Sales Forecast by Type (2022-2027)
        4.2.2 Global Endoparasiticide Revenue Forecast by Type (2022-2027)
        4.2.3 Global Endoparasiticide Price Forecast by Type (2022-2027)
5 Global Endoparasiticide Market Size by Application
    5.1 Global Endoparasiticide Historic Market Review by Application (2016-2021)
        5.1.1 Global Endoparasiticide Sales Market Share by Application (2016-2021)
        5.1.2 Global Endoparasiticide Revenue Market Share by Application (2016-2021)
        5.1.3 Global Endoparasiticide Price by Application (2016-2021)
    5.2 Global Endoparasiticide Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Endoparasiticide Sales Forecast by Application (2022-2027)
        5.2.2 Global Endoparasiticide Revenue Forecast by Application (2022-2027)
        5.2.3 Global Endoparasiticide Price Forecast by Application (2022-2027)

6 North America Endoparasiticide Market Facts & Figures
    6.1 North America Endoparasiticide Sales by Company
        6.1.1 North America Endoparasiticide Sales by Company (2016-2021)
        6.1.2 North America Endoparasiticide Revenue by Company (2016-2021)
    6.2 North America Endoparasiticide Sales Breakdown by Type
        6.2.1 North America Endoparasiticide Sales Breakdown by Type (2016-2021)
        6.2.2 North America Endoparasiticide Sales Breakdown by Type (2022-2027)
    6.3 North America Endoparasiticide Sales Breakdown by Application
        6.3.1 North America Endoparasiticide Sales Breakdown by Application (2016-2021)
        6.3.2 North America Endoparasiticide Sales Breakdown by Application (2022-2027)

7 Europe Endoparasiticide Market Facts & Figures
    7.1 Europe Endoparasiticide Sales by Company
        7.1.1 Europe Endoparasiticide Sales by Company (2016-2021)
        7.1.2 Europe Endoparasiticide Revenue by Company (2016-2021)
    7.2 Europe Endoparasiticide Sales Breakdown by Type
        7.2.1 Europe Endoparasiticide Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Endoparasiticide Sales Breakdown by Type (2022-2027)
    7.3 Europe Endoparasiticide Sales Breakdown by Application
        7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Endoparasiticide Market Facts & Figures
    8.1 China Endoparasiticide Sales by Company
        8.1.1 China Endoparasiticide Sales by Company (2016-2021)
        8.1.2 China Endoparasiticide Revenue by Company (2016-2021)
    8.2 China Endoparasiticide Sales Breakdown by Type
        8.2.1 China Endoparasiticide Sales Breakdown by Type (2016-2021)
        8.2.2 China Endoparasiticide Sales Breakdown by Type (2022-2027)
    8.3 China Endoparasiticide Sales Breakdown by Application
        8.3.1 China 242 Sales Breakdown by Application (2016-2021)
        8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Endoparasiticide Market Facts & Figures
    9.1 Japan Endoparasiticide Sales by Company
        9.1.1 Japan Endoparasiticide Sales by Company (2016-2021)
        9.1.2 Japan Endoparasiticide Revenue by Company (2016-2021)
    9.2 Japan Endoparasiticide Sales Breakdown by Type
        9.2.1 Japan Endoparasiticide Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Endoparasiticide Sales Breakdown by Type (2022-2027)
    9.3 Japan Endoparasiticide Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Endoparasiticide Market Facts & Figures
    10.1 Southeast Asia Endoparasiticide Sales by Company
        10.1.1 Southeast Asia Endoparasiticide Sales by Company (2016-2021)
        10.1.2 Southeast Asia Endoparasiticide Revenue by Company (2016-2021)
    10.2 Southeast Asia Endoparasiticide Sales Breakdown by Type
        10.2.1 Southeast Asia Endoparasiticide Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Endoparasiticide Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Endoparasiticide Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Endoparasiticide Market Facts & Figures
    11.1 India Endoparasiticide Sales by Company
        11.1.1 India Endoparasiticide Sales by Company (2016-2021)
        11.1.2 India Endoparasiticide Revenue by Company (2016-2021)
    11.2 India Endoparasiticide Sales Breakdown by Type
        11.2.1 India Endoparasiticide Sales Breakdown by Type (2016-2021)
        11.2.2 India Endoparasiticide Sales Breakdown by Type (2022-2027)
    11.3 India Endoparasiticide Sales Breakdown by Application
        11.3.1 India Endoparasiticide Sales Breakdown by Application (2016-2021)
        11.3.2 India Endoparasiticide Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Endoparasiticide Business
    12.1 Boehringer Ingelheim
        12.1.1 Boehringer Ingelheim Corporation Information
        12.1.2 Boehringer Ingelheim Business Overview
        12.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Boehringer Ingelheim Endoparasiticide Products Offered
        12.1.5 Boehringer Ingelheim Recent Development
    12.2 Elanco
        12.2.1 Elanco Corporation Information
        12.2.2 Elanco Business Overview
        12.2.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Elanco Endoparasiticide Products Offered
        12.2.5 Elanco Recent Development
    12.3 Zoetis
        12.3.1 Zoetis Corporation Information
        12.3.2 Zoetis Business Overview
        12.3.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Zoetis Endoparasiticide Products Offered
        12.3.5 Zoetis Recent Development
    12.4 Merck
        12.4.1 Merck Corporation Information
        12.4.2 Merck Business Overview
        12.4.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Merck Endoparasiticide Products Offered
        12.4.5 Merck Recent Development
    12.5 Virbac
        12.5.1 Virbac Corporation Information
        12.5.2 Virbac Business Overview
        12.5.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Virbac Endoparasiticide Products Offered
        12.5.5 Virbac Recent Development
    12.6 Novartis AG
        12.6.1 Novartis AG Corporation Information
        12.6.2 Novartis AG Business Overview
        12.6.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Novartis AG Endoparasiticide Products Offered
        12.6.5 Novartis AG Recent Development
    12.7 Ceva Sante Animlae
        12.7.1 Ceva Sante Animlae Corporation Information
        12.7.2 Ceva Sante Animlae Business Overview
        12.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Ceva Sante Animlae Endoparasiticide Products Offered
        12.7.5 Ceva Sante Animlae Recent Development
    12.8 Bayer AG
        12.8.1 Bayer AG Corporation Information
        12.8.2 Bayer AG Business Overview
        12.8.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Bayer AG Endoparasiticide Products Offered
        12.8.5 Bayer AG Recent Development
    12.9 Eli Lilly
        12.9.1 Eli Lilly Corporation Information
        12.9.2 Eli Lilly Business Overview
        12.9.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Eli Lilly Endoparasiticide Products Offered
        12.9.5 Eli Lilly Recent Development
    12.10 Vetoquinol
        12.10.1 Vetoquinol Corporation Information
        12.10.2 Vetoquinol Business Overview
        12.10.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Vetoquinol Endoparasiticide Products Offered
        12.10.5 Vetoquinol Recent Development

13 Endoparasiticide Manufacturing Cost Analysis
    13.1 Endoparasiticide Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Endoparasiticide
    13.4 Endoparasiticide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Endoparasiticide Distributors List
    14.3 Endoparasiticide Customers

15 Market Dynamics
    15.1 Endoparasiticide Market Trends
    15.2 Endoparasiticide Drivers
    15.3 Endoparasiticide Market Challenges
    15.4 Endoparasiticide Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Endoparasiticide Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Endoparasiticide Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Endoparasiticide Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Endoparasiticide Sales (K Units) by Region (2016-2021)
    Table 5. Global Endoparasiticide Sales Market Share by Region (2016-2021)
    Table 6. Global Endoparasiticide Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Endoparasiticide Revenue Share by Region (2016-2021)
    Table 8. Global Endoparasiticide Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Endoparasiticide Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Endoparasiticide Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Endoparasiticide Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Endoparasiticide Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Endoparasiticide Sales Share by Company (2016-2021)
    Table 14. Global Endoparasiticide Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Endoparasiticide Revenue Share by Company (2016-2021)
    Table 16. Global Endoparasiticide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endoparasiticide as of 2020)
    Table 17. Global Endoparasiticide Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Endoparasiticide Manufacturing Sites and Area Served
    Table 19. Manufacturers Endoparasiticide Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Endoparasiticide Sales (K Units) by Type (2016-2021)
    Table 22. Global Endoparasiticide Sales Share by Type (2016-2021)
    Table 23. Global Endoparasiticide Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Endoparasiticide Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Endoparasiticide Sales Share by Type (2022-2027)
    Table 26. Global Endoparasiticide Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Endoparasiticide Revenue Share by Type (2022-2027)
    Table 28. Global Endoparasiticide Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Endoparasiticide Sales (K Units) by Application (2016-2021) 
    Table 30. Global Endoparasiticide Sales Share by Application (2016-2021)
    Table 31. Global Endoparasiticide Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Endoparasiticide Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Endoparasiticide Sales (K Units) by Application (2022-2027)
    Table 34. Global Endoparasiticide Sales Share by Application (2022-2027)
    Table 35. Global Endoparasiticide Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Endoparasiticide Revenue Share by Application (2022-2027)
    Table 37. Global Endoparasiticide Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Endoparasiticide Sales (K Units) by Company (2016-2021)
    Table 39. North America Endoparasiticide Sales Market Share by Company (2016-2021)
    Table 40. North America Endoparasiticide Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Endoparasiticide Revenue Market Share by Company (2016-2021)
    Table 42. North America Endoparasiticide Sales by Type (2016-2021) & (K Units)
    Table 43. North America Endoparasiticide Sales Market Share by Type (2016-2021)
    Table 44. North America Endoparasiticide Sales by Type (2022-2027) & (K Units)
    Table 45. North America Endoparasiticide Sales Market Share by Type (2022-2027)
    Table 46. North America Endoparasiticide Sales by Application (2016-2021) & (K Units)
    Table 47. North America Endoparasiticide Sales Market Share by Application (2016-2021)
    Table 48. North America Endoparasiticide Sales by Application (2022-2027) & (K Units)
    Table 49. North America Endoparasiticide Sales Market Share by Application (2022-2027)
    Table 50. Europe Endoparasiticide Sales (K Units) by Company (2016-2021)
    Table 51. Europe Endoparasiticide Sales Market Share by Company (2016-2021)
    Table 52. Europe Endoparasiticide Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Endoparasiticide Revenue Market Share by Company (2016-2021)
    Table 54. Europe Endoparasiticide Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Endoparasiticide Sales Market Share by Type (2016-2021)
    Table 56. Europe Endoparasiticide Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Endoparasiticide Sales Market Share by Type (2022-2027)
    Table 58. Europe Endoparasiticide Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Endoparasiticide Sales Market Share by Application (2016-2021)
    Table 60. Europe Endoparasiticide Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Endoparasiticide Sales Market Share by Application (2022-2027)
    Table 62. China Endoparasiticide Sales (K Units) by Company (2016-2021)
    Table 63. China Endoparasiticide Sales Market Share by Company (2016-2021)
    Table 64. China Endoparasiticide Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Endoparasiticide Revenue Market Share by Company (2016-2021)
    Table 66. China Endoparasiticide Sales by Type (2016-2021) & (K Units)
    Table 67. China Endoparasiticide Sales Market Share by Type (2016-2021)
    Table 68. China Endoparasiticide Sales by Type (2022-2027) & (K Units)
    Table 69. China Endoparasiticide Sales Market Share by Type (2022-2027)
    Table 70. China Endoparasiticide Sales by Application (2016-2021) & (K Units)
    Table 71. China Endoparasiticide Sales Market Share by Application (2016-2021)
    Table 72. China Endoparasiticide Sales by Application (2022-2027) & (K Units)
    Table 73. China Endoparasiticide Sales Market Share by Application (2022-2027)
    Table 74. Japan Endoparasiticide Sales (K Units) by Company (2016-2021)
    Table 75. Japan Endoparasiticide Sales Market Share by Company (2016-2021)
    Table 76. Japan Endoparasiticide Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Endoparasiticide Revenue Market Share by Company (2016-2021)
    Table 78. Japan Endoparasiticide Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Endoparasiticide Sales Market Share by Type (2016-2021)
    Table 80. Japan Endoparasiticide Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Endoparasiticide Sales Market Share by Type (2022-2027)
    Table 82. Japan Endoparasiticide Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Endoparasiticide Sales Market Share by Application (2016-2021)
    Table 84. Japan Endoparasiticide Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Endoparasiticide Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Endoparasiticide Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Endoparasiticide Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Endoparasiticide Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Endoparasiticide Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Endoparasiticide Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Endoparasiticide Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Endoparasiticide Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Endoparasiticide Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Endoparasiticide Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Endoparasiticide Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Endoparasiticide Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Endoparasiticide Sales Market Share by Application (2022-2027)
    Table 98. India Endoparasiticide Sales (K Units) by Company (2016-2021)
    Table 99. India Endoparasiticide Sales Market Share by Company (2016-2021)
    Table 100. India Endoparasiticide Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Endoparasiticide Revenue Market Share by Company (2016-2021)
    Table 102. India Endoparasiticide Sales by Type (2016-2021) & (K Units)
    Table 103. India Endoparasiticide Sales Market Share by Type (2016-2021)
    Table 104. India Endoparasiticide Sales by Type (2022-2027) & (K Units)
    Table 105. India Endoparasiticide Sales Market Share by Type (2022-2027)
    Table 106. India Endoparasiticide Sales by Application (2016-2021) & (K Units)
    Table 107. India Endoparasiticide Sales Market Share by Application (2016-2021)
    Table 108. India Endoparasiticide Sales by Application (2022-2027) & (K Units)
    Table 109. India Endoparasiticide Sales Market Share by Application (2022-2027)
    Table 110. Boehringer Ingelheim Corporation Information
    Table 111. Boehringer Ingelheim Description and Business Overview
    Table 112. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Boehringer Ingelheim Endoparasiticide Product
    Table 114. Boehringer Ingelheim Recent Development
    Table 115. Elanco Corporation Information
    Table 116. Elanco Description and Business Overview
    Table 117. Elanco Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. Elanco Endoparasiticide Product
    Table 119. Elanco Recent Development
    Table 120. Zoetis Corporation Information
    Table 121. Zoetis Description and Business Overview
    Table 122. Zoetis Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Zoetis Endoparasiticide Product
    Table 124. Zoetis Recent Development
    Table 125. Merck Corporation Information
    Table 126. Merck Description and Business Overview
    Table 127. Merck Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Merck Endoparasiticide Product
    Table 129. Merck Recent Development
    Table 130. Virbac Corporation Information
    Table 131. Virbac Description and Business Overview
    Table 132. Virbac Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Virbac Endoparasiticide Product
    Table 134. Virbac Recent Development
    Table 135. Novartis AG Corporation Information
    Table 136. Novartis AG Description and Business Overview
    Table 137. Novartis AG Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. Novartis AG Endoparasiticide Product
    Table 139. Novartis AG Recent Development
    Table 140. Ceva Sante Animlae Corporation Information
    Table 141. Ceva Sante Animlae Description and Business Overview
    Table 142. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. Ceva Sante Animlae Endoparasiticide Product
    Table 144. Ceva Sante Animlae Recent Development
    Table 145. Bayer AG Corporation Information
    Table 146. Bayer AG Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. Bayer AG Description and Business Overview
    Table 148. Bayer AG Endoparasiticide Product
    Table 149. Bayer AG Recent Development
    Table 150. Eli Lilly Corporation Information
    Table 151. Eli Lilly Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 152. Eli Lilly Description and Business Overview
    Table 153. Eli Lilly Endoparasiticide Product
    Table 154. Eli Lilly Recent Development
    Table 155. Vetoquinol Corporation Information
    Table 156. Vetoquinol Description and Business Overview
    Table 157. Vetoquinol Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 158. Vetoquinol Endoparasiticide Product
    Table 159. Vetoquinol Recent Development
    Table 160. Production Base and Market Concentration Rate of Raw Material
    Table 161. Key Suppliers of Raw Materials
    Table 162. Endoparasiticide Distributors List
    Table 163. Endoparasiticide Customers List
    Table 164. Endoparasiticide Market Trends
    Table 165. Endoparasiticide Market Drivers
    Table 166. Endoparasiticide Market Challenges
    Table 167. Endoparasiticide Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Endoparasiticide Product Picture
    Figure 2. Global Endoparasiticide Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Endoparasiticide Sales Market Share by Application in 2021 & 2027
    Figure 6. Veterinary Hospitals or Clinics Examples
    Figure 7. Animal Farms Examples
    Figure 8. Home Care Settings Examples
    Figure 9. Global Endoparasiticide Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Endoparasiticide Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Endoparasiticide Sales (K Units) Growth Rate (2016-2027)
    Figure 12. Global Endoparasiticide Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 13. Global Endoparasiticide Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Endoparasiticide Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Endoparasiticide Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Endoparasiticide Sales (K Units) Growth Rate (2016-2027)
    Figure 17. Europe Endoparasiticide Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Endoparasiticide Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Endoparasiticide Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Endoparasiticide Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Endoparasiticide Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Endoparasiticide Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Endoparasiticide Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Endoparasiticide Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Endoparasiticide Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Endoparasiticide Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Endoparasiticide Players Market Share by Revenue in Endoparasiticide: 2016 & 2020
    Figure 28. Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Endoparasiticide Revenue Share by Type (2016-2021)
    Figure 30. Global Endoparasiticide Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Endoparasiticide Revenue Share by Application (2016-2021)
    Figure 32. Global Endoparasiticide Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Endoparasiticide Sales Market Share by Type in 2020
    Figure 34. North America Endoparasiticide Sales Market Share by Application in 2020
    Figure 35. Europe Endoparasiticide Sales Market Share by Type in 2020
    Figure 36. Europe Endoparasiticide Sales Market Share by Application in 2020
    Figure 37. China Endoparasiticide Sales Market Share by Type in 2020
    Figure 38. China Endoparasiticide Sales Market Share by Application in 2020
    Figure 39. Japan Endoparasiticide Sales Market Share by Type in 2020
    Figure 40. Japan Endoparasiticide Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Endoparasiticide Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Endoparasiticide Sales Market Share by Application in 2020
    Figure 43. India Endoparasiticide Sales Market Share by Type in 2020
    Figure 44. India Endoparasiticide Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Endoparasiticide 
    Figure 47. Manufacturing Process Analysis of Endoparasiticide
    Figure 48. Endoparasiticide Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
Frequently Asked Questions
Endoparasiticide report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Endoparasiticide report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Endoparasiticide report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Organic Filler

Market Analysis and Insights: Global Organic Filler Market
The global Organic Fille ... Read More

Vanadium Steel

Market Analysis and Insights: Global Vanadium Steel Market
The global Vanadium Stee ... Read More